NICE issues final no for Sanofi's Zaltrap
This article was originally published in Scrip
Executive Summary
After a protracted appraisal including an appeal from Sanofi, NICE has finally issued binding guidance refusing to recommend Zaltrap (aflibercept) to treat colorectal cancer.